Affiliation:
1. College of Clinical Medicine, Hunan University of Chinese Medicine, Changsha, China
2. Department of Clinical Laboratory, The Second People’s Hospital of Hunan Province, Changsha, China
Abstract
:
The Transforming Growth Factor-β (TGF-β) mediates embryonic development, maintains
cellular homeostasis, regulates immune function, and is involved in a wide range of other biological
processes. TGF-β superfamily signaling pathways play an important role in cancer development
and can promote or inhibit tumorigenesis. Type III TGF-β receptor (TGFBR3) is a co-receptor
in the TGF-β signaling pathway, which often occurs with reduced or complete loss of expression
in many cancer patients and can act as a tumor suppressor gene. The reduction or deletion of
TGFBR3 is more pronounced compared to other elements in the TGF-β signaling pathway. In recent
years, lung cancer is one of the major malignant tumors that endanger human health, and its
prognosis is poor. Recent studies have reported that TGFBR3 expression decreases to varying degrees
in different types of lung cancer, both at the tissue level and at the cellular level. The invasion,
metastasis, angiogenesis, and apoptosis of lung cancer cells are closely related to the expression
of TGFBR3, which strengthens the inhibitory function of TGFBR3 in the evolution of lung
cancer. This article reviews the mechanism of TGFBR3 in lung cancer and the influencing factors
associated with TGFBR3. Clarifying the physiological function of TGFBR3 and its molecular
mechanism in lung cancer is conducive to the diagnosis and treatment of lung cancer.
Publisher
Bentham Science Publishers Ltd.